Bayer refused patent for its anti-cancer drug
The Indian Patent Office has refused a patent application by the German pharma major Bayer Healthcare for a salt form of its anti-cancer drug Sorafenib, known under the brand Nexavar. Bayer's sorafenib drug Nexavar was the first to have a compulsory license in India.
The patent office has cited the lack of inventive step (Section 2(1)(ja), Section 3(d), Section 3(e) and finally Section 25(1)(h) of The Patents Act, 1970, as the basis of the refusal of the patent for which a pre-grant opposition was filed by Hyderabad-based Natco Pharma and Gurgaon-based Fresinius Kabi Oncology.............more
Mahindra & Mahindra objects to illegal use of its trademark
A Secunderabad-based electrical goods manufacturer ‘Mahindra Industries’ which had been illegally using the ‘Mahindra’ trademark is now at the receiving end as its premises were raided for the confiscating the alleged infringing goods.
The raid following an order for ex-parte ad interim injunction revealed large quantities of infringing goods, including ceiling fans, printed cartons, packaging material, etc, bearing the mark ‘Mahindra’. Mahindra’s product brands such as Satyam, Duro, Scorpio, Rise and XUV500 were used as model names for the ‘Mahindra Deluxe’ range of fans...............more
e-filing facility for GI applications launched
The office of the CGPDTM has launched the e-filing facility for applications for registration of Geographical Indications (GI). Now the GI applications can be submitted online to the Registrar of GI at www.ipindia.gov.in or www.ipindia.nic.in..........more